Baidu
map
TRANSPLANTATION 润色咨询

TRANSPLANTATION

出版年份:1963 年文章数:4189 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:11.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:器官移植<br>经验分享:每轮审稿大概一个月 大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0<br>经验分享:第一次投这个杂志,已online。贡献一下进度: <br> 2018年 <br> 4.22 submit <br> 4.23 with editor <br> 4.25 under review <br> 5.23 decision in process <br> 5.29 major revision <br> 9.6 accepted <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0<br>偏重的研究方向:器官移植<br>经验分享:2022-11-1 投稿,2022-12-3 Decision in prosess, 快5个工作日了,焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:器官移植;移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向:移植<br>经验分享:请各位指教:6.28投稿,投稿后状态显示:Submissions Being Processed,6.29收到稿件号确认邮件。至今进入后状态一直显示:Similarity Check/iThenticate Results (29%),我是要降重然后重新投嘛?还是等编辑回复呀,谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向:移植;肝移植<br>经验分享:6-21投稿,不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor,2021-1-20投稿,几天后开始under review,2021-2-19 Decision in process,2021-2-20 Decision in process,至今状态仍为Decision in process。Decision in process已有一周了,不知是否正常?希望有投稿经验的朋友给予指导,谢谢!祈求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578033, encodeId=58c45e803353, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:移植领域权威期刊,写了一篇letter,14号早上投稿,15号晚上decision in process,本以为凉了,16号早上看到直接接收!难以置信的一次经历,mark!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Thu Oct 17 00:00:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
    2024-05-06 reject 来自重庆

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:器官移植
    经验分享:每轮审稿大概一个月 大修了一次

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:器官移植<br>经验分享:每轮审稿大概一个月 大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0<br>经验分享:第一次投这个杂志,已online。贡献一下进度: <br> 2018年 <br> 4.22 submit <br> 4.23 with editor <br> 4.25 under review <br> 5.23 decision in process <br> 5.29 major revision <br> 9.6 accepted <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0<br>偏重的研究方向:器官移植<br>经验分享:2022-11-1 投稿,2022-12-3 Decision in prosess, 快5个工作日了,焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:器官移植;移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向:移植<br>经验分享:请各位指教:6.28投稿,投稿后状态显示:Submissions Being Processed,6.29收到稿件号确认邮件。至今进入后状态一直显示:Similarity Check/iThenticate Results (29%),我是要降重然后重新投嘛?还是等编辑回复呀,谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向:移植;肝移植<br>经验分享:6-21投稿,不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor,2021-1-20投稿,几天后开始under review,2021-2-19 Decision in process,2021-2-20 Decision in process,至今状态仍为Decision in process。Decision in process已有一周了,不知是否正常?希望有投稿经验的朋友给予指导,谢谢!祈求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578033, encodeId=58c45e803353, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:移植领域权威期刊,写了一篇letter,14号早上投稿,15号晚上decision in process,本以为凉了,16号早上看到直接接收!难以置信的一次经历,mark!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Thu Oct 17 00:00:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
    2024-05-18 ms2000001222319062 来自北京

    审稿速度:2.0 | 投稿命中率:75.0
    经验分享:1

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:器官移植<br>经验分享:每轮审稿大概一个月 大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0<br>经验分享:第一次投这个杂志,已online。贡献一下进度: <br> 2018年 <br> 4.22 submit <br> 4.23 with editor <br> 4.25 under review <br> 5.23 decision in process <br> 5.29 major revision <br> 9.6 accepted <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0<br>偏重的研究方向:器官移植<br>经验分享:2022-11-1 投稿,2022-12-3 Decision in prosess, 快5个工作日了,焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:器官移植;移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向:移植<br>经验分享:请各位指教:6.28投稿,投稿后状态显示:Submissions Being Processed,6.29收到稿件号确认邮件。至今进入后状态一直显示:Similarity Check/iThenticate Results (29%),我是要降重然后重新投嘛?还是等编辑回复呀,谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向:移植;肝移植<br>经验分享:6-21投稿,不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor,2021-1-20投稿,几天后开始under review,2021-2-19 Decision in process,2021-2-20 Decision in process,至今状态仍为Decision in process。Decision in process已有一周了,不知是否正常?希望有投稿经验的朋友给予指导,谢谢!祈求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578033, encodeId=58c45e803353, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:移植领域权威期刊,写了一篇letter,14号早上投稿,15号晚上decision in process,本以为凉了,16号早上看到直接接收!难以置信的一次经历,mark!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Thu Oct 17 00:00:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
    2019-01-09 122c9d8am23(暂无昵称)

    审稿速度:1.0
    经验分享:第一次投这个杂志,已online。贡献一下进度:
    2018年
    4.22 submit
    4.23 with editor
    4.25 under review
    5.23 decision in process
    5.29 major revision
    9.6 accepted

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:器官移植<br>经验分享:每轮审稿大概一个月 大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0<br>经验分享:第一次投这个杂志,已online。贡献一下进度: <br> 2018年 <br> 4.22 submit <br> 4.23 with editor <br> 4.25 under review <br> 5.23 decision in process <br> 5.29 major revision <br> 9.6 accepted <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0<br>偏重的研究方向:器官移植<br>经验分享:2022-11-1 投稿,2022-12-3 Decision in prosess, 快5个工作日了,焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:器官移植;移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向:移植<br>经验分享:请各位指教:6.28投稿,投稿后状态显示:Submissions Being Processed,6.29收到稿件号确认邮件。至今进入后状态一直显示:Similarity Check/iThenticate Results (29%),我是要降重然后重新投嘛?还是等编辑回复呀,谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向:移植;肝移植<br>经验分享:6-21投稿,不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor,2021-1-20投稿,几天后开始under review,2021-2-19 Decision in process,2021-2-20 Decision in process,至今状态仍为Decision in process。Decision in process已有一周了,不知是否正常?希望有投稿经验的朋友给予指导,谢谢!祈求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578033, encodeId=58c45e803353, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:移植领域权威期刊,写了一篇letter,14号早上投稿,15号晚上decision in process,本以为凉了,16号早上看到直接接收!难以置信的一次经历,mark!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Thu Oct 17 00:00:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
    2022-12-08 还是要多读多写呀 来自辽宁省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:移植
    经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:器官移植<br>经验分享:每轮审稿大概一个月 大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0<br>经验分享:第一次投这个杂志,已online。贡献一下进度: <br> 2018年 <br> 4.22 submit <br> 4.23 with editor <br> 4.25 under review <br> 5.23 decision in process <br> 5.29 major revision <br> 9.6 accepted <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0<br>偏重的研究方向:器官移植<br>经验分享:2022-11-1 投稿,2022-12-3 Decision in prosess, 快5个工作日了,焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:器官移植;移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向:移植<br>经验分享:请各位指教:6.28投稿,投稿后状态显示:Submissions Being Processed,6.29收到稿件号确认邮件。至今进入后状态一直显示:Similarity Check/iThenticate Results (29%),我是要降重然后重新投嘛?还是等编辑回复呀,谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向:移植;肝移植<br>经验分享:6-21投稿,不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor,2021-1-20投稿,几天后开始under review,2021-2-19 Decision in process,2021-2-20 Decision in process,至今状态仍为Decision in process。Decision in process已有一周了,不知是否正常?希望有投稿经验的朋友给予指导,谢谢!祈求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578033, encodeId=58c45e803353, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:移植领域权威期刊,写了一篇letter,14号早上投稿,15号晚上decision in process,本以为凉了,16号早上看到直接接收!难以置信的一次经历,mark!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Thu Oct 17 00:00:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
    2022-12-08 1dd7fa94m57(暂无匿称) 来自上海

    审稿速度:1.0
    偏重的研究方向:器官移植
    经验分享:2022-11-1 投稿,2022-12-3 Decision in prosess, 快5个工作日了,焦急的等待

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:器官移植<br>经验分享:每轮审稿大概一个月 大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0<br>经验分享:第一次投这个杂志,已online。贡献一下进度: <br> 2018年 <br> 4.22 submit <br> 4.23 with editor <br> 4.25 under review <br> 5.23 decision in process <br> 5.29 major revision <br> 9.6 accepted <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0<br>偏重的研究方向:器官移植<br>经验分享:2022-11-1 投稿,2022-12-3 Decision in prosess, 快5个工作日了,焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:器官移植;移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向:移植<br>经验分享:请各位指教:6.28投稿,投稿后状态显示:Submissions Being Processed,6.29收到稿件号确认邮件。至今进入后状态一直显示:Similarity Check/iThenticate Results (29%),我是要降重然后重新投嘛?还是等编辑回复呀,谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向:移植;肝移植<br>经验分享:6-21投稿,不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor,2021-1-20投稿,几天后开始under review,2021-2-19 Decision in process,2021-2-20 Decision in process,至今状态仍为Decision in process。Decision in process已有一周了,不知是否正常?希望有投稿经验的朋友给予指导,谢谢!祈求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578033, encodeId=58c45e803353, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:移植领域权威期刊,写了一篇letter,14号早上投稿,15号晚上decision in process,本以为凉了,16号早上看到直接接收!难以置信的一次经历,mark!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Thu Oct 17 00:00:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
    2022-12-08 还是要多读多写呀 来自辽宁省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:器官移植;移植
    经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:器官移植<br>经验分享:每轮审稿大概一个月 大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0<br>经验分享:第一次投这个杂志,已online。贡献一下进度: <br> 2018年 <br> 4.22 submit <br> 4.23 with editor <br> 4.25 under review <br> 5.23 decision in process <br> 5.29 major revision <br> 9.6 accepted <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0<br>偏重的研究方向:器官移植<br>经验分享:2022-11-1 投稿,2022-12-3 Decision in prosess, 快5个工作日了,焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:器官移植;移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向:移植<br>经验分享:请各位指教:6.28投稿,投稿后状态显示:Submissions Being Processed,6.29收到稿件号确认邮件。至今进入后状态一直显示:Similarity Check/iThenticate Results (29%),我是要降重然后重新投嘛?还是等编辑回复呀,谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向:移植;肝移植<br>经验分享:6-21投稿,不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor,2021-1-20投稿,几天后开始under review,2021-2-19 Decision in process,2021-2-20 Decision in process,至今状态仍为Decision in process。Decision in process已有一周了,不知是否正常?希望有投稿经验的朋友给予指导,谢谢!祈求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578033, encodeId=58c45e803353, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:移植领域权威期刊,写了一篇letter,14号早上投稿,15号晚上decision in process,本以为凉了,16号早上看到直接接收!难以置信的一次经历,mark!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Thu Oct 17 00:00:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
    2022-07-05 还是要多读多写呀

    偏重的研究方向:移植
    经验分享:请各位指教:6.28投稿,投稿后状态显示:Submissions Being Processed,6.29收到稿件号确认邮件。至今进入后状态一直显示:Similarity Check/iThenticate Results (29%),我是要降重然后重新投嘛?还是等编辑回复呀,谢谢各位。

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:器官移植<br>经验分享:每轮审稿大概一个月 大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0<br>经验分享:第一次投这个杂志,已online。贡献一下进度: <br> 2018年 <br> 4.22 submit <br> 4.23 with editor <br> 4.25 under review <br> 5.23 decision in process <br> 5.29 major revision <br> 9.6 accepted <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0<br>偏重的研究方向:器官移植<br>经验分享:2022-11-1 投稿,2022-12-3 Decision in prosess, 快5个工作日了,焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:器官移植;移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向:移植<br>经验分享:请各位指教:6.28投稿,投稿后状态显示:Submissions Being Processed,6.29收到稿件号确认邮件。至今进入后状态一直显示:Similarity Check/iThenticate Results (29%),我是要降重然后重新投嘛?还是等编辑回复呀,谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向:移植;肝移植<br>经验分享:6-21投稿,不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor,2021-1-20投稿,几天后开始under review,2021-2-19 Decision in process,2021-2-20 Decision in process,至今状态仍为Decision in process。Decision in process已有一周了,不知是否正常?希望有投稿经验的朋友给予指导,谢谢!祈求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578033, encodeId=58c45e803353, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:移植领域权威期刊,写了一篇letter,14号早上投稿,15号晚上decision in process,本以为凉了,16号早上看到直接接收!难以置信的一次经历,mark!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Thu Oct 17 00:00:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
    2022-07-19 lancet1111

    偏重的研究方向:移植;肝移植
    经验分享:6-21投稿,不知结果咋样

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:器官移植<br>经验分享:每轮审稿大概一个月 大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0<br>经验分享:第一次投这个杂志,已online。贡献一下进度: <br> 2018年 <br> 4.22 submit <br> 4.23 with editor <br> 4.25 under review <br> 5.23 decision in process <br> 5.29 major revision <br> 9.6 accepted <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0<br>偏重的研究方向:器官移植<br>经验分享:2022-11-1 投稿,2022-12-3 Decision in prosess, 快5个工作日了,焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:器官移植;移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向:移植<br>经验分享:请各位指教:6.28投稿,投稿后状态显示:Submissions Being Processed,6.29收到稿件号确认邮件。至今进入后状态一直显示:Similarity Check/iThenticate Results (29%),我是要降重然后重新投嘛?还是等编辑回复呀,谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向:移植;肝移植<br>经验分享:6-21投稿,不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor,2021-1-20投稿,几天后开始under review,2021-2-19 Decision in process,2021-2-20 Decision in process,至今状态仍为Decision in process。Decision in process已有一周了,不知是否正常?希望有投稿经验的朋友给予指导,谢谢!祈求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578033, encodeId=58c45e803353, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:移植领域权威期刊,写了一篇letter,14号早上投稿,15号晚上decision in process,本以为凉了,16号早上看到直接接收!难以置信的一次经历,mark!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Thu Oct 17 00:00:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
    2021-02-27 1e235a1cm31(暂无匿称)

    letter to editor,2021-1-20投稿,几天后开始under review,2021-2-19 Decision in process,2021-2-20 Decision in process,至今状态仍为Decision in process。Decision in process已有一周了,不知是否正常?希望有投稿经验的朋友给予指导,谢谢!祈求好运!

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:器官移植<br>经验分享:每轮审稿大概一个月 大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0<br>经验分享:第一次投这个杂志,已online。贡献一下进度: <br> 2018年 <br> 4.22 submit <br> 4.23 with editor <br> 4.25 under review <br> 5.23 decision in process <br> 5.29 major revision <br> 9.6 accepted <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0<br>偏重的研究方向:器官移植<br>经验分享:2022-11-1 投稿,2022-12-3 Decision in prosess, 快5个工作日了,焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:器官移植;移植<br>经验分享:2022.06.28投稿,期间送审两位专家,大修,补实验申请延期1个月,2022.12.07 accept.编辑很好,回复邮件非常迅速(应该是一般当天上班看到即回复),借用导师的话:老牌杂志,靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向:移植<br>经验分享:请各位指教:6.28投稿,投稿后状态显示:Submissions Being Processed,6.29收到稿件号确认邮件。至今进入后状态一直显示:Similarity Check/iThenticate Results (29%),我是要降重然后重新投嘛?还是等编辑回复呀,谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向:移植;肝移植<br>经验分享:6-21投稿,不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor,2021-1-20投稿,几天后开始under review,2021-2-19 Decision in process,2021-2-20 Decision in process,至今状态仍为Decision in process。Decision in process已有一周了,不知是否正常?希望有投稿经验的朋友给予指导,谢谢!祈求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578033, encodeId=58c45e803353, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:移植领域权威期刊,写了一篇letter,14号早上投稿,15号晚上decision in process,本以为凉了,16号早上看到直接接收!难以置信的一次经历,mark!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Thu Oct 17 00:00:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
    2019-10-17 Furion

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:移植领域权威期刊,写了一篇letter,14号早上投稿,15号晚上decision in process,本以为凉了,16号早上看到直接接收!难以置信的一次经历,mark!

    2

    展开2条回复
共51条页码: 1/6页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map